C07D 235/26
Oxygen atoms
C07D235/26 (Oxygen atoms) appears on 506 US grants and 431 published applications in this corpus.
Search patents in C07D- Granted patents
- 506
- Published applications
- 431
- Assignees
- 298
- Inventors
- 1,751
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 3 | 0 |
| 1978 | 14 | 0 |
| 1979 | 13 | 0 |
| 1980 | 9 | 0 |
| 1981 | 15 | 0 |
| 1982 | 7 | 0 |
| 1983 | 6 | 0 |
| 1984 | 5 | 0 |
| 1985 | 8 | 0 |
| 1986 | 4 | 0 |
| 1987 | 2 | 0 |
| 1988 | 4 | 0 |
| 1989 | 5 | 0 |
| 1990 | 9 | 0 |
| 1991 | 8 | 0 |
| 1992 | 5 | 0 |
| 1993 | 10 | 0 |
| 1994 | 10 | 0 |
| 1995 | 13 | 0 |
| 1996 | 8 | 0 |
| 1997 | 12 | 0 |
| 1998 | 20 | 0 |
| 1999 | 15 | 0 |
| 2000 | 14 | 0 |
| 2001 | 14 | 3 |
| 2002 | 11 | 20 |
| 2003 | 14 | 17 |
| 2004 | 4 | 18 |
| 2005 | 10 | 24 |
| 2006 | 11 | 28 |
| 2007 | 17 | 22 |
| 2008 | 10 | 18 |
| 2009 | 15 | 29 |
| 2010 | 12 | 25 |
| 2011 | 7 | 15 |
| 2012 | 12 | 25 |
| 2013 | 18 | 13 |
| 2014 | 16 | 17 |
| 2015 | 18 | 22 |
| 2016 | 9 | 20 |
| 2017 | 13 | 10 |
| 2018 | 9 | 10 |
| 2019 | 11 | 14 |
| 2020 | 10 | 14 |
| 2021 | 8 | 10 |
| 2022 | 10 | 11 |
| 2023 | 4 | 12 |
| 2024 | 7 | 18 |
| 2025 | 7 | 9 |
| 2026 | 6 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- N-(benzoyl)-phenylalanine compound, pharmaceutical composition containing same, and use thereof30 Jun 2026US 12,668,575 B2Apeloa Pharmaceutical Co., Ltd.
- Benzimidazolone-based cinnamamide derivative as TRPV1 antagonist and pharmaceutical composition for treatment or prevention of pain containing same as active ingredient16 Jun 2026US 12,653,814 B2Jmackem Co., Ltd
- Compounds19 May 2026US 12,630,516 B2NRG Therapeutics Ltd
- Small molecule GRB2 stabilizers for Ras map kinase inhibition14 Apr 2026US 12,599,583 B2Board of Regents, The University of Texas System
- Fused-heterocyclyl-carbonohydrazonoyl dicyanide compounds and use thereof31 Mar 2026US 12,590,066 B2Korea Institute of Science and Technology
- Novel benzimidazolone derivative compound as autotaxin inhibitor10 Sep 2026US 2026/0265265 A1LG Chem.Ltd.
- Substituted Hydroxystilbene Compounds and Derivatives, Synthesis and Uses Thereof23 Jul 2026US 2026/0209152 A1Kynan Duke IP, LLC
- Inhibitors of mark4 and methods of use28 May 2026US 2026/0146031 A1The Regents of the University of California
- Pannexin-1 modulators and methods of treating disorders in which pannexin-1 is implicated28 May 2026US 2026/0146041 A1Pannex Therapeutics Inc.
- N-(benzhydryl)cycloalkylcarboxamide derivatives as inhibitors of glycogen synthase 1 (gys1) and methods of use thereof26 Mar 2026US 2026/0085034 A1Maze Therapeutics, Inc.
Most cited
By later US patents
- Aryl piperazinyl-(C.sub.2 or C.sub.4) alkylene heterocyclic compounds having neuroleptic activity127US 4,831,031 APfizer Inc. · 1989
- Aryloxypropanolamine .beta. 3 adrenergic agonists115US 5,541,204 ABristol-Myers Squibb Company · 1996
- Fluoroalkoxy substituted benzimidazoles useful as gastric acid secretion inhibitors91US 4,758,579 AByk Gulden Lomberg Chemische Fabrik GmbH · 1988
- Inhibitors of factor Xa89US 6,534,535 B1Millennium Pharmaceuticals, Inc. · 2003
- Terpene amino alcohols and medicinal uses thereof84US 4,946,857 AKuraray Co., Ltd. · 1990